VEGFA and diabetic retinopathy: The in vitro model that was used in this study, based on a single treatment of HREC with HG for 48 h, mimics the late phase of diabetic retinopathy, during which the release of VEGF-A increases without inducing a significant effect on endothelium proliferation (data not shown).